Viral Vectors In Veterinary Vaccine Development A Textbook

Viral Vectors In Veterinary Vaccine Development A Textbook | File size: 4 MB | Format: PDF | Categories: Basic Sciences > Immunology > Viral Vectors in Veterinary Vaccine Development: A Textbook

Digital veterinary textbook. Instant download after purchase.

Save 30% — Limited time offer!

Table of Contents

• Contributors (p.10)
• 1 Evaluation and triage of the critically ill patient (p.27)
• References (p.32)
• 2 Physical examination and daily assessment of the critically ill patient (p.35)
• References (p.40)
• 3 Hemostasis (p.41)
• 1 Initiation: (p.41)
• 2 Extension: (p.42)
• References (p.46)
• 4 Cardiopulmonary resuscitation (p.48)
• References (p.53)
• 5 Postcardiac arrest care (p.56)
• References (p.61)
• 6 Classification and initial management of shock states (p.63)
• References (p.67)
• 7 SIRS, MODS, and sepsis (p.68)
• References (p.73)
• 8 Oxygen toxicity (p.75)
• References (p.79)
• 9 The endothelial surface layer (p.81)
• References (p.85)
• 10 Hyperthermia and fever (p.87)
• References (p.92)
• 11 Interstitial edema (p.93)
• References (p.97)
• 12 Patient suffering in the intensive care unit (p.98)
• References (p.100)
• 13 Predictive scoring systems in veterinary medicine (p.101)
• References (p.104)
• 14 Control of breathing (p.106)
• References (p.110)
• 15 Oxygen therapy (p.111)
• References (p.114)
• 16 Hypoxemia (p.115)
• References (p.120)
• 17 Hypoventilation (p.121)
• References (p.126)
• 18 Upper airway disease (p.127)
• References (p.135)
• 19 Tracheal collapse: Management & indications for tracheal stents (p.139)
• References (p.144)
• 20 Feline bronchopulmonary disease (p.145)
• References (p.147)
• 21 Lower airway disease in dogs (p.148)
• References (p.151)
• 22 Pulmonary hypertension (p.153)
• References (p.157)
• 23 Pulmonary edema (p.158)
• References (p.162)
• 24 Pneumonia (p.164)
• References (p.172)
• 25 Acute respiratory distress syndrome (p.175)
• References (p.178)
• 26 Pulmonary contusions and hemorrhage (p.180)
• References (p.185)
• 27 Pulmonary thromboembolism (p.187)
• References (p.190)
• 28 Chest wall disease (p.192)
• References (p.195)
• 29 Pleural space disease (p.197)
• References (p.202)
• 30 Respiratory distress look-alikes (p.204)
• References (p.206)
• 31 High flow nasal oxygen (p.208)
• References (p.210)
• 32 Mechanical ventilationcore concepts (p.212)
• References (p.219)
• 33 Mechanical ventilationadvanced concepts (p.220)
• References (p.223)
• 34 Jet ventilation (p.225)
• References (p.227)
• 35 Ventilator waveforms (p.228)
• References (p.237)
• 36 Anesthesia and monitoring of the ventilator patient (p.239)
• References (p.244)
• 37 Nursing care of the ventilator patient (p.246)
• References (p.249)
• 38 Discontinuing mechanical ventilation (p.250)
• References (p.253)
• 39 Ventilator-induced lung injury (p.254)
• References (p.257)
• 40 Ventilator-associated pneumonia (p.259)
• References (p.263)
• 41 Mechanisms of heart failure (p.265)
• References (p.269)
• 42 Ventricular failure and myocardial infarction (p.270)
• References (p.272)
• 43 Feline cardiomyopathy (p.273)
• References (p.279)
• 44 Canine cardiomyopathy (p.282)
• References (p.285)
• 45 Canine myxomatous mitral valve disease (p.287)
• References (p.291)
• 46 Blunt cardiac injury (p.293)
• References (p.296)
• 47 Pericardial diseases (p.298)
• References (p.305)
• 48 Bradyarrhythmias and conduction disturbances (p.306)
• References (p.309)
• 49 Supraventricular tachyarrhythmias (p.310)
• References (p.316)
• 50 Ventricular tachyarrhythmias (p.318)
• References (p.322)
• 51 Myocarditis (p.323)
• References (p.325)
• 52 Cardiac biomarkers (p.327)
• References (p.329)
• 53 Systemic hypertension (p.331)
• References (p.334)
• 54 Cardiopulmonary bypass (p.336)
• References (p.341)
• 55 Sodium disorders (p.343)
• References (p.351)
• 56 Potassium disorders (p.353)
• References (p.358)
• 57 Calcium disorders (p.360)
• References (p.366)
• 58 Magnesium and phosphate disorders (p.369)
• References (p.375)
• 59 Traditional acid-base analysis (p.377)
• References (p.382)
• 60 Nontraditional acid-base analysis (p.384)
• References (p.388)
• 61 Hyperlactatemia (p.389)
• References (p.393)
• 62 Urine osmolality and electrolytes (p.396)
• References (p.399)
• 63 Assessment of hydration (p.400)
• References (p.403)
• 64 Assessment of intravascular volume (p.405)
• References (p.411)
• 65 Crystalloids and hemoglobin-based oxygen-carrying solutions (p.413)
• References (p.416)
• 66 Colloid solutions (p.418)
• References (p.421)
• 67 Daily intravenous fluid therapy (p.423)
• References (p.427)
• 68 Shock fluids and fluid challenge (p.429)
• References (p.433)
• 69 Transfusion medicine (p.436)
• References (p.441)
• 70 Blood types, pretransfusion compatibility, and transfusion reactions (p.443)
• References (p.447)
• 71 Hemorrhagic shock (p.449)
• References (p.454)
• 72 The diabetic patient in the ICU (p.456)
• References (p.458)
• 73 Diabetic ketoacidosis (p.459)
• References (p.463)
• 74 Hyperglycemic hyperosmolar syndrome (p.465)
• References (p.469)
• 75 Hypoglycemia (p.471)
• References (p.476)
• 76 Diabetes insipidus (p.478)
• References (p.480)
• 77 Syndrome of inappropriate antidiuretic hormone secretion (p.481)
• References (p.483)
• 78 Thyroid storm (p.484)
• References (p.487)
• 79 Hypothyroid crisis in the dog (p.488)
• References (p.490)
• 80 Pheochromocytoma (p.492)
• References (p.495)
• 81 Critical illness-related corticosteroid insufficiency (p.497)
• References (p.500)
• 82 Hypoadrenocorticism (p.502)
• References (p.505)
• 83 Neurological evaluation of the ICU patient (p.507)
• References (p.515)
• 84 Seizures and status epilepticus (p.517)
• References (p.521)
• 85 Intracranial hypertension (p.522)
• References (p.528)
• 86 Tetanus (p.530)
• References (p.533)
• 87 Hepatic encephalopathy (p.535)
• References (p.537)
• 88 Hospital-associated infections and zoonoses (p.539)
• References (p.541)
• 89 Febrile neutropenia (p.542)
• References (p.546)
• 90 Sepsis and septic shock (p.548)
• References (p.553)
• 91 Bacterial infections (p.556)
• References (p.559)
• 92 Fungal infections (p.561)
• References (p.565)
• 93 Viral infections (p.567)
• References (p.572)
• 94 Canine parvovirus infection (p.573)
• References (p.576)
• 95 Infective endocarditis (p.578)
• References (p.584)
• 96 Urosepsis (p.586)
• References (p.591)
• 97 Necrotizing soft tissue infections (p.593)
• References (p.596)
• 98 Catheter-related bloodstream infections (p.598)
• References (p.603)
• 99 Multidrug-resistant infections (p.605)
• References (p.607)
• 100 Infectious disease control in the ICU (p.609)
• References (p.612)
• 101 Hypercoagulable states (p.613)
• References (p.619)
• 102 Feline aortic thromboembolism (p.624)
• References (p.627)
• 103 Platelet disorders (p.628)
• References (p.635)
• 104 Coagulopathy in the ICU (p.637)
• References (p.643)
• 105 Management of the bleeding patient in the ICU (p.644)
• References (p.646)
• 106 Anemia in the ICU (p.648)
• References (p.652)
• 107 Dyshemoglobinemias (p.653)
• References (p.659)
• 108 Acute hemolytic disorders (p.661)
• References (p.667)
• 109 Acute abdominal pain (p.669)
• References (p.672)
• 110 Acute pancreatitis (p.673)
• References (p.678)
• 111 Acute cholecystitis (p.680)
• References (p.683)
• 112 Hepatitis and cholangiohepatitis (p.684)
• References (p.688)
• 113 Hepatic failure (p.689)
• References (p.695)
• 114 Portal hypertension (p.697)
• References (p.702)
• 115 Portosystemic shunt management (p.704)
• References (p.707)
• 116 Acute gastroenteritis (p.709)
• References (p.713)
• 117 Gastrointestinal hemorrhage (p.714)
• References (p.718)
• 118 Regurgitation and vomiting (p.720)
• References (p.724)
• 119 Diarrhea (p.725)
• References (p.728)
• 120 Peritonitis (p.730)
• References (p.733)
• 121 Acute kidney injury (p.735)
• References (p.740)
• 122 Chronic kidney disease (p.742)
• References (p.748)
• 123 Kidney transplantation (p.750)
• References (p.756)
• 124 Nutritional assessment (p.758)
• References (p.763)
• 125 Nutritional modulation of critical illness (p.764)
• References (p.767)
• 126 Enteral nutrition (p.769)
• References (p.773)
• 127 Parenteral nutrition (p.775)
• References (p.778)
• 128 Traumatic brain injury (p.780)
• References (p.784)
• 129 Wound management (p.785)
• References (p.792)
• 130 Thermal burn injury (p.794)
• References (p.798)
• 131 Pain assessment (p.799)
• References (p.803)
• 132 Sedation of the critically ill patient (p.805)
• References (p.806)
• 133 Anesthesia in the critically ill patient (p.807)
• References (p.814)
• 134 Analgesia and constant rate infusions (p.816)
• References (p.822)
• 135 Physical rehabilitation for the critical care patient (p.824)
• References (p.828)
• 136 Integrative veterinary medicine for the intensive care unit patient (p.830)
• References (p.832)
• 137 Smoke inhalation (p.834)
• References (p.838)
• 138 Hypothermia (p.840)
• References (p.845)
• 139 Heat stroke (p.847)
• References (p.850)
• 140 Drowning and submersion injury (p.852)
• References (p.854)
• 141 Anaphylaxis (p.856)
• References (p.860)
• 142 Gas embolism (p.861)
• References (p.864)
• 143 Subcutaneous emphysema (p.865)
• References (p.868)
• 144 Ocular disease in the intensive care unit (p.870)
• References (p.874)
• 145 Critically ill neonatal and pediatric patients (p.875)
• References (p.879)
• 146 Critically ill geriatric patients (p.881)
• References (p.884)
• 147 Catecholamines (p.885)
• References (p.889)
• 148 Vasopressin (p.891)
• References (p.895)
• 149 Antihypertensives (p.897)
• References (p.901)
• 150 Pimobendan (p.902)
• References (p.905)
• 151 Diuretics (p.907)
• References (p.911)
• 152 Appetite stimulants (p.912)
• References (p.914)
• 153 Gastrointestinal protectants (p.916)
• References (p.918)
• 154 Antiemetics and prokinetics (p.920)
• References (p.923)
• 155 Opioid agonists and antagonists (p.925)
• References (p.930)
• 156 Benzodiazepines (p.932)
• References (p.934)
• 157 α₂-agonists and antagonists (p.935)
• References (p.937)
• 158 Nonsteroidal antiinflammatory drugs (p.941)
• References (p.947)
• 159 Gabapentin (p.949)
• References (p.951)
• 160 Tramadol (p.952)
• References (p.954)
• 161 Trazodone (p.955)
• References (p.956)
• 162 Cannabinoid medicine in intensive care unit patients (p.958)
• References (p.961)
• 163 Anticonvulsants (p.962)
• References (p.965)
• 164 Antiplatelet drugs (p.967)
• References (p.971)
• 165 Anticoagulants (p.973)
• References (p.979)
• 166 Thrombolytic agents (p.981)
• References (p.984)
• 167 Hemostatic drugs (p.986)
• References (p.989)
• 168 Antiarrhythmic agents (p.991)
• References (p.995)
• 169 Inhaled medications (p.997)
• References (p.1001)
• 170 Complications of chemotherapy agents (p.1002)
• References (p.1006)
• 171 Antitoxins and antivenoms (p.1008)
• References (p.1011)
• 172 Antimicrobial use in the critical care patient (p.1013)
• References (p.1019)
• 173 β-lactam antimicrobials (p.1021)
• References (p.1023)
• 174 Aminoglycosides (p.1025)
• References (p.1029)
• 175 Fluoroquinolones (p.1031)
• References (p.1035)
• 176 Antifungal therapy (p.1037)
• References (p.1040)
• 177 Miscellaneous antibiotics (p.1041)
• References (p.1045)
• 178 Renal replacement therapies (p.1047)
• References (p.1050)
• 179 Apheresis (p.1052)
• References (p.1054)
• 180 Extracorporeal therapies for blood purification (p.1056)
• References (p.1059)
• 181 Hemodynamic monitoring (p.1060)
• References (p.1065)
• 182 Cardiac output monitoring (p.1067)
• References (p.1071)
• 183 Electrocardiogram evaluation (p.1073)
• References (p.1078)
• 184 Oximetry monitoring (p.1079)
• References (p.1082)
• 185 Colloid osmotic pressure and osmolality (p.1084)
• References (p.1088)
• 186 Coagulation and platelet monitoring (p.1089)
• References (p.1093)
• 187 Viscoelastic monitoring (p.1094)
• References (p.1099)
• 188 Intraabdominal pressure monitoring (p.1101)
• References (p.1104)
• 189 Point-of-care ultrasound in the ICU (p.1106)
• References (p.1121)
• 190 Capnography (p.1123)
• References (p.1126)
• 191 Intracranial pressure monitoring (p.1127)
• References (p.1131)
• 192 Urine output (p.1133)
• References (p.1136)
• 193 Peripheral venous catheterization (p.1137)
• References (p.1141)
• 194 Intraosseous catheterization (p.1142)
• References (p.1146)
• 195 Central venous catheterization (p.1147)
• References (p.1153)
• 196 Blood film evaluation (p.1155)
• References (p.1160)
• 197 Endotracheal intubation and tracheostomy (p.1161)
• References (p.1165)
• 198 Thoracocentesis (p.1167)
• References (p.1170)
• 199 Thoracostomy tube placement and drainage (p.1172)
• References (p.1176)
• 200 Abdominocentesis (p.1177)
• References (p.1179)
• 201 Arterial catheterization (p.1180)
• References (p.1183)
• 202 Blood gas sampling (p.1184)
• References (p.1186)
• 203 Temporary cardiac pacing (p.1188)
• References (p.1193)
• 204 Cardioversion (p.1194)
• References (p.1196)
• 205 Defibrillation (p.1197)
• References (p.1199)
• 206 Cerebrospinal fluid sampling and interpretation (p.1200)
• 1 Preparation for CSF tap (p.1201)
• 2 CSF collection sites and techniques (p.1201)
• References (p.1205)
• 207 Urinary catheterization (p.1207)
• References (p.1211)
• 208 Urinary diversion techniques (p.1213)
• References (p.1217)
• 209 Intensive care unit facility design (p.1219)
• References (p.1226)
• 210 Management of the intensive care unit (p.1228)
• References (p.1231)
• 211 Client communication, grief, and veterinary wellness (p.1232)
• References (p.1235)
• 212 Prevention of compassion fatigue and burnout (p.1237)
• References (p.1242)
• Index (p.1250)
• ... and 3151 more chapters

🔗 Download Link:

Frequently bought together

Viral Vectors In Veterinary Vaccine Development...

HK$200.00

HK$200.00

Claim Offer